The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $47.55

Today's change-0.71 -1.47%
Updated July 21 4:04 PM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $47.55

Today's change-0.71 -1.47%
Updated July 21 4:04 PM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA crosses below 50-day moving average

Fresenius Medical Care AG & Co KGaA closed lower Friday, dropping (U.S.)$0.71 or 1.47% to (U.S.)$47.55 and crossing below its 50-day moving average. Shares have lost 3.55% over the last five days, but have gained 12.65% over the last year to date. This security has underperformed the S&P 500 by 7.34% during the last year.

Key company metrics

  • Open(U.S.) $47.39
  • Previous close(U.S.) $48.26
  • High(U.S.) $47.59
  • Low(U.S.) $47.20
  • Bid / Ask-- / --
  • YTD % change+12.65%
  • Volume221,771
  • Average volume (10-day)124,058
  • Average volume (1-month)121,935
  • Average volume (3-month)139,793
  • 52-week range(U.S.) $38.05 to (U.S.) $50.22
  • Beta0.48
  • Trailing P/E22.02×
  • P/E 1 year forward20.93×
  • Forward PEG2.11×
  • Indicated annual dividend(U.S.) $0.53
  • Dividend yield1.12%
  • Trailing EPS(U.S.) $2.16
Updated July 21 4:04 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.53%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue4,5484,6874,5984,420
Total other revenue--------
Total revenue4,5484,6874,5984,420
Gross profit1,5921,5921,4721,399
Total cost of revenue2,9563,0953,1273,022
Total operating expense3,8973,9013,9283,779
Selling / general / administrative944742791729
Research & development32424439
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income651786670641
Interest income (expense), net non-operating-121-106-110-120
Gain (loss) on sale of assets--------
Other--------
Income before tax559688570539
Income after tax377476406370
Income tax, total182212164168
Net income308388333294
Total adjustments to net income--------
Net income before extra. items308388333294
Minority interest-69-88-73-76
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items308388333294
Inc. avail. to common incl. extra. items308388333294
Diluted net income308388333294
Dilution adjustment--000
Diluted weighted average shares306307307306
Diluted EPS excluding extraordinary itemsvalue per share1.011.261.090.96
Dividends per sharevalue per share0.00------
Diluted normalized EPSvalue per share1.011.261.090.96